You are here: Industry Insights > FDA

News List

FDA fast-tracks recreational drug MDMA for treatment of PTSD pharmafile
August 31, 2017
In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to MDMA for the treatment of post-traumatic stress disorder (PTSD).
FDA approval brings first gene therapy to the United States worldpharmanews
August 31, 2017
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
FDA approves first U.S. treatment for Chagas disease worldpharmanews
August 31, 2017
The U.S. Food and Drug Administration has granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease.
FDA approves new antibacterial drug europeanpharmaceuticalreview
August 31, 2017
The FDA has approved Vabomere for adults with complicated urinary tract infections…
FDA Approves New Antibacterial Drug pharmaceutical-technology
August 31, 2017
The U.S. Food and Drug Administration approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria.
FDA Approves First U.S. Treatment for Chagas Disease pharmaceutical-technology
August 31, 2017
The U.S. Food and Drug Administration granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease.
FDA Accepts Pegvaliase BLA, Grants Priority Review Designation pharmaceutical-technology
August 31, 2017
BioMarin announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for pegvaliase, a PEGylated recombinant phenylalanine ammonia lyase enzyme product, to reduce blood phenylalanine (Phe)
Boehringer Ingelheim Receives FDA Approval for Cyltezo americanpharmaceuticalreview
August 31, 2017
Boehringer Ingelheim announced the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases
FDA approves AstraZeneca’s faslodex for expanded use in breast cancer pharmaceutical-technology
August 31, 2017
AstraZeneca’s faslodex (fulvestrant) at 500mg has received approval from the US Food and Drug Administration (FDA) as monotherapy for expanded use in women with advanced breast cancer.
FDA Anounces GDUFA Rates for fiscal year 2018 contractpharma
August 30, 2017
FDA has announced fiscal year 2018 rates under GDUFA for contract manufacturing organization facilities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 367 368 Next page